FDA Inspection 1191274 — Franco Locatelli, M.D. Ph.D.
The FDA completed an inspection of Franco Locatelli, M.D. Ph.D. on Oct 28, 2022 in Rome. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 28, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rome (Italy)
Additional Details
Clinical Investigator (CI)